Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2008-4-14
pubmed:abstractText
Emerging lines of evidence have suggested that certain dysfibrinogens present a significant risk of thrombosis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0049-3848
pubmed:author
pubmed:issnType
Print
pubmed:volume
121
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
773-80
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:17854865-Adult, pubmed-meshheading:17854865-Amino Acid Substitution, pubmed-meshheading:17854865-Calcium, pubmed-meshheading:17854865-Catalysis, pubmed-meshheading:17854865-Electrophoresis, Polyacrylamide Gel, pubmed-meshheading:17854865-Female, pubmed-meshheading:17854865-Fibrin, pubmed-meshheading:17854865-Fibrinogen, pubmed-meshheading:17854865-Fibrinogens, Abnormal, pubmed-meshheading:17854865-Fibrinolysin, pubmed-meshheading:17854865-Humans, pubmed-meshheading:17854865-Ions, pubmed-meshheading:17854865-Microscopy, Electron, Scanning, pubmed-meshheading:17854865-Polymerase Chain Reaction, pubmed-meshheading:17854865-Postpartum Period, pubmed-meshheading:17854865-Solubility, pubmed-meshheading:17854865-Surface Properties, pubmed-meshheading:17854865-Thrombin, pubmed-meshheading:17854865-Thrombophilia, pubmed-meshheading:17854865-Time Factors, pubmed-meshheading:17854865-Tissue Plasminogen Activator, pubmed-meshheading:17854865-Venous Thrombosis
pubmed:year
2008
pubmed:articleTitle
Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.
pubmed:affiliation
Research Division of Cell and Molecular Medicine, Center for Molecular Medicine, Jichi Medical University, School of Medicine, Shimotsuke, Tochigi-ken 329-0498, Japan.
pubmed:publicationType
Journal Article, Case Reports, Research Support, Non-U.S. Gov't